Le Lézard
Classified in: Health
Subject: CALENDAR OF EVENTS

Theratechnologies to Announce Second Quarter 2022 Financial Results and Provide Business Update


MONTREAL, July 07, 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a biopharmaceutical company focused on the development and commercialization of innovative therapies, announced today that it will report financial results for its second quarter of fiscal 2022 ended May 31 on Thursday, July 14, 2022.

The conference call will be held on July 14, 2022 at 8:30 a.m. (ET) to discuss the results and recent business updates. The call will be hosted by Paul Lévesque, President and Chief Executive Officer. Joining Mr. Lévesque on the call will be other members of the management team, including Chief Financial Officer Philippe Dubuc and Chief Medical Officer Christian Marsolais, who will be available to answer questions from participants following prepared remarks.  

Participants are encouraged to join the call ten minutes in advance to secure access.

Conference call dial-in and replay information is below:

CONFERENCE CALL INFORMATION
Conference Call Date:July 14, 2022
Conference Call Time:8:30 AM ET
North America Dial-in:1- 877-513-4119
International Dial-in:1- 412-902-6615
Access Code:5742327
CONFERENCE CALL REPLAY
North America Dial-in:1- 877-344-7529
International Dial-in:1- 412-317-0088
Replay Access Code: 7192794
Replay End DateJuly 21, 2022

The live conference call will be accessible via webcast at: https://edge.media-server.com/mmc/p/98pvag4g.

About Theratechnologies

Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.

Investors:
Elif McDonald
Senior Director, Investor Relations
1-438-315-8563   
[email protected] 



These press releases may also interest you

at 11:02
The American College of Clinical Pharmacology® (ACCP) is pleased to announce its 2024 ACCP Annual Meeting (#2024ACCP) will be held September 8 ? 10, 2024. We encourage you to join us for this transformative educational and scientific event! ACCP...

at 11:01
Somavedic, a trailblazer in sleep and digital pollution-neutralizing frequency therapy technology, in collaboration with researchers from the Eye Clinic of Jan Evangelista Purkyn? University and Masaryk Hospital in Ústí nad Labem in the Czech...

at 11:00
The Patient-Centered Outcomes Research Institute (PCORI) today announced the approval of funding awards totaling more than $150 million to support new patient-centered comparative clinical effectiveness research (CER) studies, research to strengthen...

at 11:00
Health Canada is advising that the following product(s) may pose serious health risks. For more information, including product photos and what you should do, visit these online safety alerts: ?  Unauthorized sexual enhancement products Health Canada...

at 11:00
Every treatment prescribed by a doctor today was once a part of research in a clinical trial. Clinical research is thriving at Thompson Cancer Survival Center....

at 10:59
According to the second annual Workplace Violence Prevention Training Annual Report for health care ? which provides insight into the state of workplace violence prevention training in health care ? the majority of health care professionals surveyed...



News published on and distributed by: